J. Fajkos et al., SYNTHESIS OF (15E)-17-BETA-HYDROXYANDROST-4-ENE-3,15-DIONE 15-(O-CARBOXYMETHYL)OXIME, A POTENTIAL HAPTEN FOR TESTOSTERONE IMMUNOASSAYS, Steroids, 61(11), 1996, pp. 634-638
The kev intermediate, 15-oxandrost-5-ene-3 beta, 17 beta-diyl 3-acetat
e 17-benzoate (10), was prepared by a five-step procedure based on the
addition of 4-methoxybenzyl alcohol to 3 beta-hydroxyandrosta-5,15-di
en-17-one (1). The resulting C-15 isomers were separated as acetates.
In both series, the 17-ketones were reduced to 17 beta-hydroxy derivat
ives and after benzoylation, the protecting methoxyphenylmethyl group
at position 15 was removed with 2,3-dichloro-5,6-dicyano-1,4-benzoquin
one, leaving 15 beta-hydroxyandrost-5-ene-3 beta,17 beta-diyl 3-acetat
e 17-benzoate (6) and its 15 alpha-isomer 9, After Jones oxidation, bo
th benzoates afforded the identical ketone 10. The reaction of 10 with
(O-carboxymethyl)hydroxylamine in pyridine followed by diazomethane e
sterification gave (15E)-15-oxandrost-5-ene-3 beta,17 beta-diyl 3-acet
ate 17-benzoate 15-(O-carboxymethyl)oxine methyl ester (11). Methyl es
ter 11 was successively submitted to acidic deacetylation, Oppenauer o
xidation, potassium hydroxide treatment, and reesterification with dia
zomethane to give (15E)-17 beta-hydroxyandrost-4-ene-3,15-dione 15-(O-
carboxymethyl)oxime methyl ester (14). After purification, ester 14 wa
s hydrolyzed with potassium hydrogen carbonate in aqueous methanol at
elevated temperature into free testosterone 15-(O-carboxymethyl)oxime
(15). (C) 1996 by Elsevier Science Inc.